HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease.

AuthorsBarrett G Levesque, William J Sandborn
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 17 Issue 6 Pg. 1443-4 (Jun 2011) ISSN: 1536-4844 [Electronic] England
PMID21560204 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Adult
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Crohn Disease (complications, drug therapy)
  • Female
  • Humans
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Infliximab
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous (etiology)
  • Mycobacterium marinum
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: